M
Miguel Angel Diaz
Researcher at Boston Children's Hospital
Publications - 251
Citations - 5906
Miguel Angel Diaz is an academic researcher from Boston Children's Hospital. The author has contributed to research in topics: Transplantation & Hematopoietic stem cell transplantation. The author has an hindex of 36, co-authored 233 publications receiving 4767 citations. Previous affiliations of Miguel Angel Diaz include Menéndez Pelayo International University & Autonomous University of Madrid.
Papers
More filters
Journal ArticleDOI
Long-term follow-up of IPEX syndrome patients after different therapeutic strategies: An international multicenter retrospective study
Federica Barzaghi,Laura C. Amaya Hernandez,Benedicte Neven,Silvia Ricci,Zeynep Yesim Kucuk,Jack J. Bleesing,Zohreh Nademi,Mary Slatter,Erlinda R. Ulloa,Anna Shcherbina,Anna Roppelt,Austen Worth,Juliana Silva,Alessandro Aiuti,Luis Murguia-Favela,Carsten Speckmann,Magda Carneiro-Sampaio,Juliana Folloni Fernandes,Safa Baris,Ahmet Ozen,Elif Karakoc-Aydiner,Ayca Kiykim,Ansgar Schulz,Sandra Steinmann,Lucia Dora Notarangelo,Eleonora Gambineri,Paolo Lionetti,William T. Shearer,Lisa R. Forbes,Caridad Martinez,Despina Moshous,Stéphane Blanche,Alain Fisher,Frank M. Ruemmele,Come Tissandier,Marie Ouachée-Chardin,Frédéric Rieux-Laucat,Marina Cavazzana,Waseem Qasim,Barbarella Lucarelli,Michael H. Albert,Ichiro Kobayashi,Laura C. Alonso,Cristina Díaz de Heredia,Hirokazu Kanegane,Anita Lawitschka,Jong Jin Seo,Marta González-Vicent,Miguel Angel Diaz,Rakesh K. Goyal,Martin Sauer,Akif Yesilipek,Minsoo Kim,Yesim Yilmaz-Demirdag,Monica Bhatia,Julie Khlevner,Erick J. Richmond Padilla,Silvana Martino,Davide Montin,Olaf Neth,Agueda Molinos-Quintana,Justo Valverde-Fernandez,Arnon Broides,Vered Pinsk,Antje Ballauf,Filomeen Haerynck,Victoria Bordon,Catharina Dhooge,Maria Laura Garcia-Lloret,Robbert G. M. Bredius,Krzysztof Kałwak,Elie Haddad,Markus G. Seidel,Gregor Dückers,Sung-Yun Pai,Sung-Yun Pai,Christopher C. Dvorak,Stephan Ehl,Franco Locatelli,Frederick D. Goldman,Andrew R. Gennery,M.J. Cowan,Maria Grazia Roncarolo,Rosa Bacchetta +83 more
TL;DR: Patients receiving chronic IS were hampered by disease recurrence or complications, impacting long‐term disease‐free survival, and when performed in patients with a low OI score, HSCT resulted in disease resolution with better quality of life, independent of age, donor source, or conditioning regimen.
Journal ArticleDOI
Response to Rituximab-Based Therapy and Risk Factor Analysis in Epstein Barr Virus–Related Lymphoproliferative Disorder After Hematopoietic Stem Cell Transplant in Children and Adults: A Study From the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation
Jan Styczyński,Lidia Gil,Gloria Tridello,Per Ljungman,Per Ljungman,J. Peter Donnelly,Walter J.F.M. van der Velden,Hamdy Omar,Rodrigo Martino,Constantijn J. M. Halkes,Maura Faraci,Koen Theunissen,Krzysztof Kałwak,Petr Hubacek,Simona Sica,Chiara Nozzoli,Franca Fagioli,Susanne Matthes,Miguel Angel Diaz,Maddalena Migliavacca,Adriana Balduzzi,Agnieszka Tomaszewska,Rafael de la Cámara,Anja van Biezen,Jennifer Hoek,Simona Iacobelli,Hermann Einsele,Simone Cesaro +27 more
TL;DR: Investigation of Epstein-Barr virus-related posttransplant lymphoproliferative disorder after a rituximab-based treatment in the allogeneic hematopoietic stem cell transplant (HSCT) setting found reduction of immunosuppression was associated with improved outcome, whereas older age, extranodal disease, and acute graft-vs-host disease predicted poor outcome.
Journal Article
Atenuación de la asimetría y de la curtosis de las puntuaciones observadas mediante transformaciones de variables: Incidencia sobre la estructura factorial
TL;DR: In this article, a trabajo se evalua la incidencia de la atenuacion, mediante transformaciones de variables, del sesgo and de la curtosis de las puntuaciones observadas, sobre la estructura factorial, estimada medianté analisis factorial exploratorio and confirmatorio.
Journal ArticleDOI
Comparison of peripheral blood progenitor cell mobilization in patients with multiple myeloma: high-dose cyclophosphamide plus GM-CSF vs G-CSF alone.
Adrian Alegre,J F Tomás,C. Martinez-Chamorro,J J Gil-Fernández,M J Fernández-Villalta,R Arranz,Miguel Angel Diaz,A Granda,M R Bernardo,A Escudero,J L López-Lorenzo,J M Fernández-Rañada +11 more
TL;DR: Although HD-CY plus GM-CSF is superior to G- CSF alone based on mean CD34+ cell yield per pheresis, adequate CD34- cell collections can be achieved with G-CSf alone in most MM patients with less toxicity and with simplification of the procedure.